Source: Annual Congress 2003 - Advances in our understanding of corticosteroids in the treatment of asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. B. Weiss, M. Buxton, L. F. Andersson, C. J. Lamm, B. Liljas, P. M. O‘Byrne, W. C. Tan, S. D. Sullivan (Chicago, Seattle, United States Of America; Uxbridge, United Kingdom; Basel, Sweden; Hamilton, Canada; Singapore, Singapore). Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study. Eur Respir J 2003; 22: Suppl. 45, 339

Member's Comments

No comment yet.

Related content which might interest you: Effectiveness of early intervention with budesonide in mild persistent asthma — 5-year data from the START study Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004 Long-term safety data with once-daily budesonide in mild asthma: results from the START study Source: Eur Respir J 2003; 22: Suppl. 45, 34s Year: 2003 The effects of early intervention with inhaled budesonide on lung function in mild persistent asthma: results from the START study Source: Eur Respir J 2003; 22: Suppl. 45, 34s Year: 2003 The cost-effectiveness of early intervention with inhaled budesonide once daily: an international comparison of the results from the START study Source: Eur Respir J 2002; 20: Suppl. 38, 43s Year: 2002 Fracture rate in patients with asthma receiving long-term early intervention with budesonide: the START study Source: Eur Respir J 2005; 26: Suppl. 49, 276s Year: 2005 Country-specific cost-effectiveness of early intervention with budesonide in mild asthma Source: Eur Respir J 2004; 24 : 568-574 Year: 2004 Follow-up results 10 years after early intervention with budesonide or terbutaline in mild persistent asthma Source: Eur Respir J 2006; 28: Suppl. 50, 667s Year: 2006 Cost-effectiveness of early intervention with budesonide once daily: Results from the START study Source: Eur Respir J 2002; 20: Suppl. 38, 43s Year: 2002 High or standard initial dose of budesonide to control mild-to-moderate asthma? Source: Eur Respir J 2001; 17: 856-862 Year: 2001 Comparative study of 8-weeks treatment of asthma exacerbations in adults with high doses of budesonide versus fluticasone Source: Eur Respir J 2001; 18: Suppl. 33, 97s Year: 2001 Early intervention with budesonide in mild persistent asthma - the START study. On behalf of the START investigators group Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002 Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021 Comparison of the efficacy of cicleosonide with budesonide in mild to moderate asthma patients after step-down therapy Source: Annual Congress 2011 - Asthma management and response Year: 2011 Intermittent tiotropium in early childhood wheezing? Preliminary safety results of a pilot study Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Phase III trial of tiotropium as add-on therapy to low-dose inhaled corticosteroids for patients with symptomatic mild persistent asthma: Design and planned analyses Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Tolerability and efficacy of budesonide/formoterol via Turbuhaler® vs standard treatment in Japanese patients with moderate to severe COPD: 52-week phase III study results Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Cost-effectiveness of formoterol turbuhaler versus salbutamol as reliever therapy in asthma: results from the RELIEF worldwide randomised effectiveness study Source: Eur Respir J 2002; 20: Suppl. 38, 43s Year: 2002 Evaluating the efficacy of omalizumab in severe persistent asthma patients Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Budesonide/formoterol in a single inhaler is well tolerated in patients with moderate to severe COPD: results of a 1-year study Source: Eur Respir J 2002; 20: Suppl. 38, 242s Year: 2002 Efficacy of the using budesonide/formoterol in patients with bronchial asthma (BA): the study of routine clinical practice Source: Eur Respir J 2006; 28: Suppl. 50, 499s Year: 2006